Abstract
Two controlled studies were conducted to evaluate the persistent efficacy of moxidectin (10%) long-acting (LA) injectable formulation against Dictyocaulus viviparus, Haemonchus placei, Trichostrongylus axei and Oesophagostomum radiatum in cattle. The moxidectin LA injectable formulation was administered as a single subcutaneous injection into the proximal third of the ear at a dose rate of 0.01ml/kg BW to provide 1.0mg moxidectin/kg BW. The product had persistent efficacy of >90% against D. viviparus, H. placei and Oe. radiatum for at least 150 days post-treatment and against T. axei for at least 90 days post-treatment.
Copyright 2009 Elsevier B.V. All rights reserved.
MeSH terms
-
Animals
-
Antinematodal Agents / administration & dosage
-
Antinematodal Agents / pharmacology*
-
Antinematodal Agents / therapeutic use
-
Cattle
-
Cattle Diseases / drug therapy
-
Cattle Diseases / parasitology*
-
Delayed-Action Preparations / administration & dosage
-
Delayed-Action Preparations / pharmacology*
-
Delayed-Action Preparations / therapeutic use
-
Feces / parasitology
-
Female
-
Gastrointestinal Diseases / drug therapy
-
Gastrointestinal Diseases / parasitology
-
Gastrointestinal Diseases / veterinary
-
Injections, Subcutaneous / veterinary
-
Lung Diseases, Parasitic / drug therapy
-
Lung Diseases, Parasitic / parasitology
-
Lung Diseases, Parasitic / veterinary
-
Macrolides / administration & dosage
-
Macrolides / pharmacology
-
Macrolides / therapeutic use
-
Male
-
Nematoda / growth & development*
-
Nematode Infections / drug therapy
-
Nematode Infections / parasitology
-
Nematode Infections / veterinary*
-
New Jersey
-
Parasite Egg Count / veterinary
-
Random Allocation
-
Statistics, Nonparametric
Substances
-
Antinematodal Agents
-
Delayed-Action Preparations
-
Macrolides
-
moxidectin